OEM News

AliveCor Rolls Out KardiaMobile 6L Max with KardiaAlert Feature

The new KardiaAlert feature compares every ECG taken against an established baseline ECG and scans for potential changes over time.

KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection. Photos: AliveCor.

AliveCor has launched KardiaMobile 6L Max personal ECG system alongside a first-of-its-kind feature called KardiaAlert.

KardiaMobile 6L Max provides in-depth reporting on ECGs, blood pressure, and weight data with remote access to board-certified cardiologists. It includes an ECG device and one-year subscription to KardiaCare.

The new KardiaAlert feature compares every ECG taken against an established baseline ECG and scans for potential changes over time, even subtle ones not visible in a single recording. These changes, according to the company, could be normal or indicate more serious conditions leading to a cardiac event.

If a change is spotted, the ECG data is transmitted to a board-certified radiologist for further review. KardiaAlert notifies patients of ECG changes so they can have more informed conversations with their clinicians.

The new, first-of-its-kind KardiaAlert feature.

“AliveCor is committed to innovating for patients, providers and the healthcare industry alike,” said Sanjay Voleti, chief business officer of AliveCor. “With the launch of KardiaMobile 6L Max and the integration of KardiaAlert, we are proud to provide patients and clinicians with the most comprehensive AI-based heart health system available over-the-counter.”

“KardiaMobile 6L Max identifies up to 20 arrhythmias with a clinician review—more than any other personal ECG—all without doctors appointments, waiting rooms, or lengthy tests. Meanwhile, KardiaAlert monitors ECGs for potential changes over time,” added Dr. David E. Albert, founder and chief medical officer of AliveCor. “These next-generation capabilities enable cardiologists to spend more time on patients who require in-person care, while simultaneously empowering patients to remotely manage their care with peace of mind.”

In January of this year, Anumana began a collaboration with AliveCor to develop Anumana’s advanced AI algorithms for early cardiac disease detection on AliveCor’s Kardia ECG devices.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters